Exact Sciences Corporation Stock
Equities
EXAS
US30063P1057
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 104.91 USD | +0.95% |
|
-.--% | +3.30% |
| 03-25 | Exact Sciences Corporation(NasdaqCM:EXAS) dropped from S&P Biotechnology Select Industry Index | CI |
| 03-25 | Exact Sciences Corporation(NasdaqCM:EXAS) dropped from S&P Global BMI Index | CI |
| Capitalization | 20.03B 17.01B 15.7B 14.8B 27.46B 1,863B 27.94B 184B 72.13B 896B 75.13B 73.56B 3,188B | P/E ratio 2024 |
-10.1x | P/E ratio 2025 | -92.2x |
|---|---|---|---|---|---|
| Enterprise value | 21.6B 18.34B 16.93B 15.96B 29.61B 2,009B 30.13B 198B 77.79B 967B 81.02B 79.32B 3,437B | EV / Sales 2024 |
4.4x | EV / Sales 2025 | 6.42x |
| Free-Float |
98.92% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Exact Sciences Corporation
| 1 day | +0.95% | ||
| 1 month | +1.02% | ||
| 3 months | +2.42% | ||
| 6 months | +71.17% | ||
| Current year | +3.30% |
| 1 month | 103.72 |  | 104.98 |
| Current year | 101.51 | | 104.98 |
| 1 year | 38.81 | | 104.98 |
| 3 years | 38.81 | | 104.98 |
| 5 years | 29.27 | | 140.18 |
| 10 years | 5.36 | | 159.54 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.95% | -.--% | +148.25% | +57.07% | 20.03B | |
| -2.97% | +5.36% | +4.76% | +50.62% | 2.62B | |
| +0.32% | +1.38% | -16.28% | -46.42% | 2.27B | |
| -3.10% | +5.07% | +87.98% | +78.00% | 2.17B | |
| -0.52% | -5.24% | +23.78% | -32.62% | 1.57B | |
| -2.68% | +17.95% | +296.07% | - | 1.05B | |
| +27.60% | +34.33% | +23.05% | +152.48% | 1.15B | |
| +2.26% | +6.64% | +2.68% | -7.43% | 776M | |
| +0.59% | -0.29% | -7.32% | -10.38% | 703M | |
| -2.57% | +9.65% | +98.26% | -75.83% | 499M | |
| Average | +2.13% | +7.51% | +66.12% | +18.39% | 3.28B | |
| Weighted average by Cap. | +1.11% | +2.67% | +108.30% | +44.45% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.76B 2.34B 2.16B 2.04B 3.78B 257B 3.85B 25.35B 9.94B 124B 10.35B 10.13B 439B | 3.25B 2.76B 2.55B 2.4B 4.45B 302B 4.53B 29.84B 11.7B 145B 12.18B 11.93B 517B |
| Net income | -1.03B -874M -807M -761M -1.41B -95.73B -1.44B -9.45B -3.71B -46.06B -3.86B -3.78B -164B | -208M -177M -163M -154M -285M -19.35B -290M -1.91B -749M -9.31B -780M -764M -33.1B |
| Net Debt | 1.74B 1.48B 1.36B 1.28B 2.38B 162B 2.42B 15.97B 6.26B 77.79B 6.52B 6.38B 277B | 1.57B 1.33B 1.23B 1.16B 2.15B 146B 2.19B 14.43B 5.66B 70.29B 5.89B 5.77B 250B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Equities
- EXAS Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition